A critical advance in cancer research is arising with the use of VHH fragments to reactivate mutated p53. This essential tumor inhibitor protein is frequently inactivated in various kinds of malignancies, causing https://peakbookmarks.com/story22029196/nanobodies-reactivate-tumor-suppressor-p53-a-new-pathway-for-malignant-treatment